Follow with a starchy snack once your glucose has stabilised
Phase 2 dose-finding data The phase 2 trial tested cagrilintide at 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg weekly
In addition to diabetes management, semaglutide is also approved for weight loss in people with obesity or those who are overweight
This study has implications for the structural understanding of the GLP-1R and related class B GPCRs, which is important for the development of new and improved therapeutics targeting these receptors
Your clinician will recommend pairing the medication with: A nutritious, protein-rich diet Physical activityespecially with strength training Hydration to support muscle recovery These habits not only support weight loss but also: Benefit your heart health Boost overall well-being Preserve lean muscle mass, which can decline during rapid weight loss How Much Weight Can You Expect to Lose with a GLP-1
J Emerg Med 2010 Sep;39(3):320-4